Coverage of "L&c bio" on Cryptosearcher: the stories and the context behind them.
L&C Bio stock surges 12% on plans to treat Ozempic face with donated human fat, tapping into a rapidly expanding market of GLP-1 drug users facing facial volume loss.
August 6, 2026
